Study of Sugammadex Versus Usual Care on Incidence of Residual Blockade at Post Anesthesia Care Unit Admission (P07981)

NCT01479764 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

154

Enrollment

INDUSTRY

Sponsor class

Conditions

Surgical Procedures, Elective

Interventions

DRUG: Sugammadex
DRUG: Neostigmine
DRUG: Glycopyrrolate

Sponsor

Merck Sharp & Dohme LLC